BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

240 related articles for article (PubMed ID: 24625754)

  • 1. A soluble form of the giant cadherin Fat1 is released from pancreatic cancer cells by ADAM10 mediated ectodomain shedding.
    Wojtalewicz N; Sadeqzadeh E; Weiß JV; Tehrani MM; Klein-Scory S; Hahn S; Schmiegel W; Warnken U; Schnölzer M; de Bock CE; Thorne RF; Schwarte-Waldhoff I
    PLoS One; 2014; 9(3):e90461. PubMed ID: 24625754
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Anticancer chemotherapy inhibits MHC class I-related chain a ectodomain shedding by downregulating ADAM10 expression in hepatocellular carcinoma.
    Kohga K; Takehara T; Tatsumi T; Miyagi T; Ishida H; Ohkawa K; Kanto T; Hiramatsu N; Hayashi N
    Cancer Res; 2009 Oct; 69(20):8050-7. PubMed ID: 19826051
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tetraspanin15 regulates cellular trafficking and activity of the ectodomain sheddase ADAM10.
    Prox J; Willenbrock M; Weber S; Lehmann T; Schmidt-Arras D; Schwanbeck R; Saftig P; Schwake M
    Cell Mol Life Sci; 2012 Sep; 69(17):2919-32. PubMed ID: 22446748
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of ADAMs in the ectodomain shedding and conformational conversion of the prion protein.
    Taylor DR; Parkin ET; Cocklin SL; Ault JR; Ashcroft AE; Turner AJ; Hooper NM
    J Biol Chem; 2009 Aug; 284(34):22590-600. PubMed ID: 19564338
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of ADAM10 as a major source of HER2 ectodomain sheddase activity in HER2 overexpressing breast cancer cells.
    Liu PC; Liu X; Li Y; Covington M; Wynn R; Huber R; Hillman M; Yang G; Ellis D; Marando C; Katiyar K; Bradley J; Abremski K; Stow M; Rupar M; Zhuo J; Li YL; Lin Q; Burns D; Xu M; Zhang C; Qian DQ; He C; Sharief V; Weng L; Agrios C; Shi E; Metcalf B; Newton R; Friedman S; Yao W; Scherle P; Hollis G; Burn TC
    Cancer Biol Ther; 2006 Jun; 5(6):657-64. PubMed ID: 16627989
    [TBL] [Abstract][Full Text] [Related]  

  • 6. ADAM10 regulates endothelial permeability and T-Cell transmigration by proteolysis of vascular endothelial cadherin.
    Schulz B; Pruessmeyer J; Maretzky T; Ludwig A; Blobel CP; Saftig P; Reiss K
    Circ Res; 2008 May; 102(10):1192-201. PubMed ID: 18420943
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Shedding of endogenous MHC class I-related chain molecules A and B from different human tumor entities: heterogeneous involvement of the "a disintegrin and metalloproteases" 10 and 17.
    Chitadze G; Lettau M; Bhat J; Wesch D; Steinle A; Fürst D; Mytilineos J; Kalthoff H; Janssen O; Oberg HH; Kabelitz D
    Int J Cancer; 2013 Oct; 133(7):1557-66. PubMed ID: 23526433
    [TBL] [Abstract][Full Text] [Related]  

  • 8. EGF promotes the shedding of soluble E-cadherin in an ADAM10-dependent manner in prostate epithelial cells.
    Grabowska MM; Sandhu B; Day ML
    Cell Signal; 2012 Feb; 24(2):532-538. PubMed ID: 22024284
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A disintegrin and metalloproteinase (ADAM)-mediated ectodomain shedding of ADAM10.
    Parkin E; Harris B
    J Neurochem; 2009 Mar; 108(6):1464-79. PubMed ID: 19183255
    [TBL] [Abstract][Full Text] [Related]  

  • 10. ADAM10 mediates E-cadherin shedding and regulates epithelial cell-cell adhesion, migration, and beta-catenin translocation.
    Maretzky T; Reiss K; Ludwig A; Buchholz J; Scholz F; Proksch E; de Strooper B; Hartmann D; Saftig P
    Proc Natl Acad Sci U S A; 2005 Jun; 102(26):9182-7. PubMed ID: 15958533
    [TBL] [Abstract][Full Text] [Related]  

  • 11. ADAM10-Mediated Ectodomain Shedding Is an Essential Driver of Podocyte Damage.
    Sachs M; Wetzel S; Reichelt J; Sachs W; Schebsdat L; Zielinski S; Seipold L; Heintz L; Müller SA; Kretz O; Lindenmeyer M; Wiech T; Huber TB; Lüllmann-Rauch R; Lichtenthaler SF; Saftig P; Meyer-Schwesinger C
    J Am Soc Nephrol; 2021 Jun; 32(6):1389-1408. PubMed ID: 33785583
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression of A disintegrin and metalloprotease 10 in pancreatic carcinoma.
    Gaida MM; Haag N; Günther F; Tschaharganeh DF; Schirmacher P; Friess H; Giese NA; Schmidt J; Wente MN
    Int J Mol Med; 2010 Aug; 26(2):281-8. PubMed ID: 20596609
    [TBL] [Abstract][Full Text] [Related]  

  • 13. ADAM10 releases a soluble form of the GPNMB/Osteoactivin extracellular domain with angiogenic properties.
    Rose AA; Annis MG; Dong Z; Pepin F; Hallett M; Park M; Siegel PM
    PLoS One; 2010 Aug; 5(8):e12093. PubMed ID: 20711474
    [TBL] [Abstract][Full Text] [Related]  

  • 14. T-cell immunoglobulin and mucin domain 2 (TIM-2) is a target of ADAM10-mediated ectodomain shedding.
    Dewitz C; Möller-Hackbarth K; Schweigert O; Reiss K; Chalaris A; Scheller J; Rose-John S
    FEBS J; 2014 Jan; 281(1):157-74. PubMed ID: 24164679
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Coxsackievirus and Adenovirus Receptor (CAR) undergoes ectodomain shedding and regulated intramembrane proteolysis (RIP).
    Houri N; Huang KC; Nalbantoglu J
    PLoS One; 2013; 8(8):e73296. PubMed ID: 24015300
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Surface expression and limited proteolysis of ADAM10 are increased by a dominant negative inhibitor of dynamin.
    Carey RM; Blusztajn JK; Slack BE
    BMC Cell Biol; 2011 May; 12():20. PubMed ID: 21586144
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fendiline inhibits proliferation and invasion of pancreatic cancer cells by interfering with ADAM10 activation and β-catenin signaling.
    Woods N; Trevino J; Coppola D; Chellappan S; Yang S; Padmanabhan J
    Oncotarget; 2015 Nov; 6(34):35931-48. PubMed ID: 26440150
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Receptor for advanced glycation end products is subjected to protein ectodomain shedding by metalloproteinases.
    Zhang L; Bukulin M; Kojro E; Roth A; Metz VV; Fahrenholz F; Nawroth PP; Bierhaus A; Postina R
    J Biol Chem; 2008 Dec; 283(51):35507-16. PubMed ID: 18952609
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ectodomain shedding of the cell adhesion molecule Nectin-4 in ovarian cancer is mediated by ADAM10 and ADAM17.
    Buchanan PC; Boylan KLM; Walcheck B; Heinze R; Geller MA; Argenta PA; Skubitz APN
    J Biol Chem; 2017 Apr; 292(15):6339-6351. PubMed ID: 28232483
    [TBL] [Abstract][Full Text] [Related]  

  • 20. ADAM10 is the major sheddase responsible for the release of membrane-associated meprin A.
    Herzog C; Haun RS; Ludwig A; Shah SV; Kaushal GP
    J Biol Chem; 2014 May; 289(19):13308-22. PubMed ID: 24662289
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.